AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates
ANABAnaptysBio(ANAB) Zacks Investment Research·2024-05-10 06:46

AnaptysBio, Inc. (ANAB) came out with a quarterly loss of 1.64pershareversustheZacksConsensusEstimateofalossof1.64 per share versus the Zacks Consensus Estimate of a loss of 1.54. This compares to loss of 1.58pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof6.491.58 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -6.49%. A quarter ago, it was expected that this company would post a loss of 1.74 per share when it actually produced a loss of $1.59, delivering a surprise of 8.62%. Over the last four quarters, the company has surpas ...